Formoterol
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
<StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='96/963800/Cv/1'> | <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='96/963800/Cv/1'> | ||
| - | Formoterol, also known as eformoterol, is a long-acting β2 agonist (LABA) used as a bronchodilator in the management of asthma and chronic obstructive pulmonary disease (COPD). Formoterol has an extended duration of action (up to 12 h) compared to short-acting β2 agonists such as salbutamol (albuterol), which are effective for 4 h to 6 h. Formoterol has a relatively rapid onset of action compared to other LABAs, and is effective within 2-3 minutes. See also [https://en.wikipedia.org/wiki/Formoterol]. | + | Formoterol, also known as eformoterol, is a long-acting β2 agonist (LABA) used as a bronchodilator in the management of asthma and chronic obstructive pulmonary disease (COPD). Formoterol has an extended duration of action (up to 12 h) compared to short-acting β2 agonists such as [[salbutamol]] (albuterol), which are effective for 4 h to 6 h. Formoterol has a relatively rapid onset of action compared to other LABAs, and is effective within 2-3 minutes. See also [https://en.wikipedia.org/wiki/Formoterol]. |
<scene name='96/963800/Overall/1'>Adrenoceptor with bound agonist formoterol</scene> ([[6tko]]). | <scene name='96/963800/Overall/1'>Adrenoceptor with bound agonist formoterol</scene> ([[6tko]]). | ||
Revision as of 12:36, 5 June 2023
| |||||||||||
